Epocrates Names Dave Burlington Chief Operations Officer

SAN MATEO, Calif.--(BUSINESS WIRE)--Epocrates, Inc., the leading developer of drug and clinical reference solutions, today announced the appointment of Dave Burlington as the company's new chief operations officer (COO). Burlington has nearly 25 years of experience in product development and management, strategy, service, delivery and launch of on-demand/SaaS architectures from a number of successful software companies.

"Dave Burlington's combination of technical skill and commercial leadership will be a great asset to Epocrates. He brings a fresh perspective and relevant experience from software and product-driven organizations in various stages of growth," said Rose Crane, chief executive officer and president for Epocrates.

Burlington most recently served as group vice president of applications and technology at Taleo Corporation, the leading provider of on-demand talent management solutions. During his five-year tenure, Burlington was responsible for all enterprise product strategy and development, and managed the company's architecture, technology and infrastructure. Burlington led efforts for three major acquisitions, and helped grow Taleo from $70 million to $240 million in revenues.

Previously, Burlington served as senior vice president of product development for Comergent Technologies, Inc., which was acquired by Sterling Commerce in 2006. He helped create and execute company-wide strategy, operating business plans and annual sales plan projections. Burlington has also held senior leadership positions at PeopleSoft, Inc., Gap, Inc. and Andersen Consulting.

"The healthcare industry is rapidly moving to digital, and embracing mobile and SaaS-based technologies that help increase efficiencies and the quality of patient care," said Burlington. "This is an exciting time to be joining Epocrates, which is at the forefront and continues to make significant contributions to the evolution of technology in medicine. I am looking forward to working with the talented teams who have made this company a leading innovator in healthcare technology."

Burlington earned a Bachelor of Science in electrical engineering from Santa Clara University.


Epocrates is a leading provider of mobile drug reference tools and interactive services to healthcare professionals and the healthcare industry. Epocrates' active user network currently has more than one million healthcare professionals, including more than 45 percent of U.S. physicians. Most commonly used on mobile devices at the point of care, the company's clinical products and services help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. For more information about Epocrates, please visit www.epocrates.com/company.

All trademarks are properties of their respective owners.



Epocrates, Inc.
Erica Sniad Morgenstern, 650-227-6907
[email protected]